NCT05374616 Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
| NCT ID | NCT05374616 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor College of Medicine |
| Condition | TANGO2-related Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2018-05-18 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2018-05-18 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to establish a biorepository of individuals with TANGO2 deficiency to support scientific research and establish a comprehensive clinical database of affected individuals to understand the disease course.
Eligibility Criteria
Inclusion Criteria: All patients with pathogenic TANGO2 variants will be included. Exclusion Criteria: Patients who do not have TANGO2-related disease will be excluded.
Frequently Asked Questions
Who can join the NCT05374616 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, studying TANGO2-related Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05374616 currently recruiting?
Yes, NCT05374616 is actively recruiting participants. Visit ClinicalTrials.gov or contact Baylor College of Medicine to inquire about joining.
Where is the NCT05374616 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05374616 clinical trial?
NCT05374616 is sponsored by Baylor College of Medicine. The trial plans to enroll 300 participants.